The briefing came after US federal health agencies on Tuesday recommended pausing the use of the vaccine after six recipients developed a rare disorder involving blood clots, in a fresh setback to global efforts to tackle the pandemic.
The move comes a week after European regulators said they had found a possible link between AstraZeneca’s Covid-19 vaccine and a rare blood clotting problem that had led to a few deaths.
TimesLIVE
